Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

ing resultsUrologyPatients with Peyronie's Disease 

Injectable Pentoxifyline Solution 

$500 M

POC studies in first half 2014; pursue commercialization strategy pending resultsPainRenal-Compromised Patients with Osteoarthritis, Joint Pain, or Inflammation

Impracor 

10% Ketoprofen Cream

$500 M

POC studies in select patient populations in 2014; begin out-licensing to pharmacies pending outcome of resultsSeelhorst continued, "Because of the near-term opportunities in the Ophthalmology therapy area, Imprimis has already begun to build a world-class commercialization team to execute in this specialized market. This team brings a wealth of experience from giants in the industry in developing and commercializing ophthalmic drugs." 

Imprimis' new strategy will be supported by clinical data to either support a 505(b)(2) development program or to give sufficient clinical confidence to a prescribing physician that their patients will benefit from the proposed therapy choice.  To support these clinical-development efforts, Imprimis has hired a Clinical Project Manager to develop and execute proof-of-concept studies for its ophthalmic, wound management and urology products.

As part of Imprimis' shift in strategic direction, Imprimis plans to consider alternative commercialization pathways for Impracor, which may include an improvement of its formulation and the licensing of such a formulation to a network of partner pharmacies.  As a result of careful consideration of the totality circumstances surrounding Impracor, the current Impracor Phase 3 clinical program has been discontinued.

With the adoption of Imprimis' new strategic initiatives, projected cash burn is expected to decrease by more than $7.5 million over the next 12 months as compared with its previous estimates.
"We believe that our reduced burn rate and the near term commercialization of some of our key
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
(Date:9/1/2015)... ... 01, 2015 , ... AdvantagePlusCaregivers.com® provides information on defining what ... to look for and expect when searching for resources, as well as a ... Park, CA by CEO, Richard Weatherman and Co-Founder Piroska Zalkadi, AdvantagePlusCaregivers.com® grew exponentially ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, standardized, outcomes-driven ... the provision of quality addiction treatment and the utilization of resources to ...
(Date:9/1/2015)... ... 2015 , ... The integration of Practice Perfect and FOTO ... to FOTO enabling cost and time savings, reducing errors and omissions, and eliminating ... Practice Perfect, stated "FOTO is a natural extension of Practice Perfect, assisting ...
(Date:9/1/2015)... ... 2015 , ... Elizabeth Callahan, MD, founder and medical director of SkinSmart ... offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides an immediate ... the hands, delivering smooth, natural-looking results that can last up to one year in ...
(Date:9/1/2015)... ... 2015 , ... Routines… every family has them. Whether it’s a morning routine, ... parents, caregivers and children too. Here are three reasons why routines can be beneficial ... fluid. When a routine is implemented into a child’s schedule, they are able to ...
Breaking Medicine News(10 mins):Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Back into the Swing of Things: How Family Routines Benefit Children 2
... TUSTIN, Calif., Oct. 1 Merlyn Medical has ... portable fluid warmer that,requires neither battery nor electric ... 2007 EMS Expo in Orlando, FL, October 11-13 ... Francisco October,14-17. "This lightweight, compact device was ...
... RESPeRATE ... Hypertension Treatment Device, NEW YORK ... today announced that its RESPeRATE(R) hypertension,treatment device, clinically-proven in ... into retail distribution in,Australia through its local marketing and ...
... arm can help save 36,000 lives this year., ... season, which will put up to 200,000 Americans in ... with an inexpensive,vaccination. AARP is urging all Americans 50-plus ... spread., (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ), "Vaccine ...
... WAKEFIELD, MA, Oct. 1 /PRNewswire-FirstCall/ - NUCRYST ... 2007 it signed amended,agreements with Smith & ... of Acticoat(TM) dressings with SILCRYST(TM) nanocrystalline coatings.,The ... in 2001, when Smith &,Nephew bought the ...
... 10 Tips on Spotting Depression in Children, BETHLEHEM, ... are affected by depression each year, but even as ... screen people and educate them,about the condition on National ... to forget a largely overlooked part of our,population: children. ...
... genetics may be to blame, researchers suggest, , , MONDAY, ... is generally considered a good thing, new research suggests ... harm the health of the fetus. , Expectant ... per deciliter (mg/dL) gave birth -- on average -- ...
Cached Medicine News:Health News:Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 3Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 4Health News:AARP Reminds All People 50-Plus to Get a Flu Shot This Year 2Health News:NUCRYST and Smith & Nephew Revise Agreements 2Health News:NUCRYST and Smith & Nephew Revise Agreements 3Health News:NUCRYST and Smith & Nephew Revise Agreements 4Health News:NUCRYST and Smith & Nephew Revise Agreements 5Health News:NUCRYST and Smith & Nephew Revise Agreements 6Health News:NUCRYST and Smith & Nephew Revise Agreements 7Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 4Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 5Health News:Mom's Low Cholesterol Tied to Preemie Births 2Health News:Mom's Low Cholesterol Tied to Preemie Births 3
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: